Abstract

Over the past 10 years, the availability of pharmacologic quantities of hematopoietic growth factors has opened many avenues of study in basic science and clinical investigation. Pharmacologic agents that accelerate hematopoietic recovery obviously have the potential to improve selected therapeutic and supportive care aspects of cancer medicine. This article reviews important clinical and scientific aspects of hematopoietic growth factors, with an emphasis on their present-day use in the care of cancer patients.

Original languageEnglish (US)
Pages (from-to)165-184
Number of pages20
JournalCa-A Cancer Journal for Clinicians
Volume46
Issue number3
DOIs
StatePublished - Jan 1 1996

Fingerprint

Intercellular Signaling Peptides and Proteins
Hematinics
Neoplasms
Patient Care
Medicine
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Hematopoietic growth factors. / Bociek, R. Gregory; Armitage, J. O.

In: Ca-A Cancer Journal for Clinicians, Vol. 46, No. 3, 01.01.1996, p. 165-184.

Research output: Contribution to journalReview article

@article{841b71e1da62416eba9fff2275906713,
title = "Hematopoietic growth factors",
abstract = "Over the past 10 years, the availability of pharmacologic quantities of hematopoietic growth factors has opened many avenues of study in basic science and clinical investigation. Pharmacologic agents that accelerate hematopoietic recovery obviously have the potential to improve selected therapeutic and supportive care aspects of cancer medicine. This article reviews important clinical and scientific aspects of hematopoietic growth factors, with an emphasis on their present-day use in the care of cancer patients.",
author = "Bociek, {R. Gregory} and Armitage, {J. O.}",
year = "1996",
month = "1",
day = "1",
doi = "10.3322/canjclin.46.3.165",
language = "English (US)",
volume = "46",
pages = "165--184",
journal = "CA Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Hematopoietic growth factors

AU - Bociek, R. Gregory

AU - Armitage, J. O.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Over the past 10 years, the availability of pharmacologic quantities of hematopoietic growth factors has opened many avenues of study in basic science and clinical investigation. Pharmacologic agents that accelerate hematopoietic recovery obviously have the potential to improve selected therapeutic and supportive care aspects of cancer medicine. This article reviews important clinical and scientific aspects of hematopoietic growth factors, with an emphasis on their present-day use in the care of cancer patients.

AB - Over the past 10 years, the availability of pharmacologic quantities of hematopoietic growth factors has opened many avenues of study in basic science and clinical investigation. Pharmacologic agents that accelerate hematopoietic recovery obviously have the potential to improve selected therapeutic and supportive care aspects of cancer medicine. This article reviews important clinical and scientific aspects of hematopoietic growth factors, with an emphasis on their present-day use in the care of cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=0029941533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029941533&partnerID=8YFLogxK

U2 - 10.3322/canjclin.46.3.165

DO - 10.3322/canjclin.46.3.165

M3 - Review article

C2 - 8646546

AN - SCOPUS:0029941533

VL - 46

SP - 165

EP - 184

JO - CA Cancer Journal for Clinicians

JF - CA Cancer Journal for Clinicians

SN - 0007-9235

IS - 3

ER -